Chronic gout: Barriers to effective management

Area of Science:

• Rheumatology
• General Practice
• Inflammatory Arthropathies

Background:

• Gout is a common inflammatory arthropathy with well-understood pathogenesis.
• Most chronic tophaceous gout (CTG) patients in Australia are managed by general practitioners (GPs).
• Continuous urate-lowering therapy (ULT) can suppress gout, reduce flares, and prevent complications like tophi and joint damage.

Purpose of the Study:

• Discuss inconsistencies in current gout treatment guidelines.
• Identify patient and physician barriers to optimal gout care.
• Provide practical recommendations for GPs to implement a treat-to-target (T2T) approach.

Main Methods:

• Literature review of gout management and treatment guidelines.
• Analysis of barriers to effective gout care in primary settings.
• Development of practical recommendations for GPs.

Main Results:

• Chronic gout is often poorly managed despite available treatments.
• Existing guidelines may have inconsistencies or be difficult for GPs to implement.
• A treat-to-target (T2T) approach is recommended, aiming for serum urate levels of 0.35 mmol/L or below.

Conclusions:

• There is a vital and overdue need for Australian gout guidelines tailored for GP implementation.
• Addressing treatment guideline inconsistencies and patient/physician barriers is crucial for improving gout management.
• Implementing a T2T strategy with ULT is essential for controlling chronic gout and preventing long-term complications.